An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say. In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years – five times longer than under chemotherapy. The patients also suffered far fewer side-effects. Cases… Read More »
ABC News: Health
GlaxoSmithKline recalls its heartburn drug Zantac WORLDWIDE amid fears it may contain a cancer-causing chemical – but it’s still available in the US and the UK GlaxoSmithKline said four different types of the medication would be recalled It’s feared pills contain NDMA, considered ‘probably carcinogenic’ to humans All four affected products are only available on… Read More »
Legislation that would put a cap on prices pharmaceutical companies can charge for their prescription drugs can be effective in reducing health costs, Humana CEO Bruce Broussard said Friday. But U.S. lawmakers should also include in their proposals rules that would facilitate greater competition and innovation, Broussard said in an interview with CNBC’s Bertha Coombs.… Read More »
FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease Print this page TOKYO–(BUSINESS WIRE)– August 28, 2019 — Kyowa Kirin Co., Ltd., (Kyowa Kirin, TYO: 4151) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Nourianz (istradefylline) for use as adjunctive treatment… Read More »
WINDSOR, Ontario (Reuters) – U.S. Senator and Democratic presidential hopeful Bernie Sanders joined diabetes patients as they drove across the border on Sunday to buy cheap insulin in Canada, highlighting his argument in favor of federally negotiated prescription drug prices. U.S. Sen. Bernie Sanders talks about the high cost of health care in the U.S.… Read More »